Active Ingredient History

  • Now
Eplivanserin was an experimental drug for the treatment of insomnia which was being developed by Sanofi Aventis.   Wikipedia

  • SMILES: CN(C)CCO\N=C(\C=C\c1ccc(O)cc1)/c2ccccc2F
  • Mol. Mass: 328.39
  • ALogP: 3.53
  • ChEMBL Molecule:
More Chemistry
2-propen-1-one, 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-, o-(2-(dimethylamino)ethyl)oxime, (z,e)-, (e)-2-butenedioate (2:1) (salt) | 4-((3z)-3-(2-dimethylaminoethyl)oxyimino-3-(2-fluorophenyl)propen-1-yl)phenol hemifumarate | eplivanserin | sr 46349 | sr-46349 | sr 46349b | sr-46349b


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue